Published in J Nucl Med on May 01, 2010
Molecular and metabolic mechanisms of cardiac dysfunction in diabetes. Life Sci (2012) 1.21
Remodeling of glucose metabolism precedes pressure overload-induced left ventricular hypertrophy: review of a hypothesis. Cardiology (2015) 1.19
Real-time noninvasive imaging of fatty acid uptake in vivo. ACS Chem Biol (2012) 1.06
Standardized bioenergetic profiling of adult mouse cardiomyocytes. Physiol Genomics (2012) 1.06
Impact of diabetes on postinfarction heart failure and left ventricular remodeling. Curr Heart Fail Rep (2011) 0.96
Albiglutide, a long lasting glucagon-like peptide-1 analog, protects the rat heart against ischemia/reperfusion injury: evidence for improving cardiac metabolic efficiency. PLoS One (2011) 0.89
Left ventricular functional assessment in murine models of ischemic and dilated cardiomyopathy using [18 F]FDG-PET: comparison with cardiac MRI and monitoring erythropoietin therapy. EJNMMI Res (2012) 0.85
Assessing Cardiac Metabolism: A Scientific Statement From the American Heart Association. Circ Res (2016) 0.82
Post-translational modifications of the cardiac proteome in diabetes and heart failure. Proteomics Clin Appl (2015) 0.81
Catabolic Defect of Branched-Chain Amino Acids Promotes Heart Failure. Circulation (2016) 0.81
Suppression of myocardial 18F-FDG uptake with a preparatory "Atkins-style" low-carbohydrate diet. Eur Radiol (2012) 0.79
Myocardial infarct size and area at risk assessment in mice. Exp Clin Cardiol (2012) 0.77
Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation (1998) 5.93
Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. N Engl J Med (2001) 4.46
The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. J Clin Invest (2002) 4.22
Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol (2002) 4.11
Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study. Circulation (2007) 3.88
Sequential contribution of L- and P-selectin to leukocyte rolling in vivo. J Exp Med (1995) 3.83
Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. J Am Coll Cardiol (2008) 3.43
Hyperpolarized 13C allows a direct measure of flux through a single enzyme-catalyzed step by NMR. Proc Natl Acad Sci U S A (2007) 3.15
Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med (1990) 3.12
The three members of the selectin receptor family recognize a common carbohydrate epitope, the sialyl Lewis(x) oligosaccharide. J Cell Biol (1992) 2.89
Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin. Circulation (2001) 2.70
In vivo assessment of pyruvate dehydrogenase flux in the heart using hyperpolarized carbon-13 magnetic resonance. Proc Natl Acad Sci U S A (2008) 2.69
Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med (1986) 2.63
F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2). J Am Coll Cardiol (2007) 2.50
Energy metabolism in heart failure and remodelling. Cardiovasc Res (2008) 2.37
Regional myocardial metabolism of high-energy phosphates during isometric exercise in patients with coronary artery disease. N Engl J Med (1990) 2.18
Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol (1992) 2.18
Analysis of tricarboxylic acid cycle of the heart using 13C isotope isomers. Am J Physiol (1990) 2.17
Myocardial ischemic memory imaging with molecular echocardiography. Circulation (2007) 2.13
Noninvasive ultrasound imaging of inflammation using microbubbles targeted to activated leukocytes. Circulation (2000) 2.07
31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy. Circulation (1998) 2.06
Assessment of endogenous and therapeutic arteriogenesis by contrast ultrasound molecular imaging of integrin expression. Circulation (2005) 2.04
Nuclear receptors PPARbeta/delta and PPARalpha direct distinct metabolic regulatory programs in the mouse heart. J Clin Invest (2007) 1.88
Altered creatine kinase adenosine triphosphate kinetics in failing hypertrophied human myocardium. Circulation (2006) 1.84
Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans. J Nucl Med (1990) 1.77
Molecular determinants of reperfusion-induced leukocyte adhesion and vascular protein leakage. Circ Res (1994) 1.64
Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial. JACC Cardiovasc Imaging (2009) 1.63
Prediction of cardiac death in hemodialysis patients by myocardial fatty acid imaging. J Am Coll Cardiol (2008) 1.62
Recruitment of compensatory pathways to sustain oxidative flux with reduced carnitine palmitoyltransferase I activity characterizes inefficiency in energy metabolism in hypertrophied hearts. Circulation (2007) 1.59
18F-FDG PET imaging of myocardial viability in an experienced center with access to 18F-FDG and integration with clinical management teams: the Ottawa-FIVE substudy of the PARR 2 trial. J Nucl Med (2010) 1.56
[18F]fluorodeoxyglucose single photon emission computed tomography: can it replace PET and thallium SPECT for the assessment of myocardial viability? Circulation (1998) 1.54
Targeted ultrasound contrast agents: in vitro assessment of endothelial dysfunction and multi-targeting to ICAM-1 and sialyl Lewisx. Biotechnol Bioeng (2005) 1.53
Myocardial 18F-FDG uptake after exercise-induced myocardial ischemia in patients with coronary artery disease. J Nucl Med (2008) 1.53
The transcriptional coactivator PGC-1alpha is essential for maximal and efficient cardiac mitochondrial fatty acid oxidation and lipid homeostasis. Am J Physiol Heart Circ Physiol (2008) 1.51
Basic acoustic properties of microbubbles. Echocardiography (2002) 1.49
In vivo myocardial kinetics of air-filled albumin microbubbles during myocardial contrast echocardiography. Comparison with radiolabeled red blood cells. Circ Res (1994) 1.48
Direct imaging of exercise-induced myocardial ischemia with fluorine-18-labeled deoxyglucose and Tc-99m-sestamibi in coronary artery disease. Circulation (2003) 1.46
Administration of an intravenous perfluorocarbon contrast agent improves echocardiographic determination of left ventricular volumes and ejection fraction: comparison with cine magnetic resonance imaging. J Am Coll Cardiol (1998) 1.46
Noninvasive imaging of inflammation by ultrasound detection of phagocytosed microbubbles. Circulation (2000) 1.43
Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol (1994) 1.40
Adhesion molecules and their role in vascular disease. Am J Hypertens (2001) 1.38
Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy. Am Heart J (1991) 1.36
Hibernating myocardium: diagnosis and patient outcomes. Curr Probl Cardiol (2007) 1.36
Metabolic imaging with beta-methyl-p-[(123)I]-iodophenyl-pentadecanoic acid identifies ischemic memory after demand ischemia. Circulation (2005) 1.34
Noninvasive imaging of myocardial reperfusion injury using leukocyte-targeted contrast echocardiography. Circulation (2002) 1.34
Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation (1995) 1.32
The absence of endogenous lipid oxidation in early stage heart failure exposes limits in lipid storage and turnover. J Mol Cell Cardiol (2007) 1.30
Cardiac carbon 13 magnetic resonance spectroscopy: on the horizon or over the rainbow? J Nucl Cardiol (2002) 1.29
Optical and acoustical dynamics of microbubble contrast agents inside neutrophils. Biophys J (2001) 1.23
Myocardial contrast echocardiography: a 25-year retrospective. Circulation (2008) 1.22
Iodofiltic acid I 123 (BMIPP) fatty acid imaging improves initial diagnosis in emergency department patients with suspected acute coronary syndromes: a multicenter trial. J Am Coll Cardiol (2010) 1.22
The effect of hyperpolarized tracer concentration on myocardial uptake and metabolism. Magn Reson Med (2009) 1.18
Quantitation of myocardial fatty acid metabolism using PET. J Nucl Med (1996) 1.15
Quantitative studies of human cardiac metabolism by 31P rotating-frame NMR. Proc Natl Acad Sci U S A (1987) 1.15
Cardiac metabolism in patients with dilated and hypertrophic cardiomyopathy: assessment with proton-decoupled P-31 MR spectroscopy. J Magn Reson Imaging (1992) 1.14
Glycogen storage disease as a unifying mechanism of disease in the PRKAG2 cardiac syndrome. Biochem Soc Trans (2003) 1.06
Time course of alterations in myocardial glucose utilization in the Zucker diabetic fatty rat with correlation to gene expression of glucose transporters: a small-animal PET investigation. J Nucl Med (2008) 1.06
Detection of coronary artery stenosis with power Doppler imaging. Circulation (2001) 1.03
Magnetic resonance spectroscopy in myocardial disease. JACC Cardiovasc Imaging (2009) 1.03
Short-term flexibility of myocardial triglycerides and diastolic function in patients with type 2 diabetes mellitus. Am J Physiol Endocrinol Metab (2008) 0.98
Investigation of [18F]2-fluoro-2-deoxyglucose for the measure of myocardial glucose metabolism. J Nucl Med (1978) 0.96
Ultrasound molecular imaging of cardiovascular disease. Nat Clin Pract Cardiovasc Med (2008) 0.96
Myocardial perfusion, oxidative metabolism, and free fatty acid uptake in patients with hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene: a positron emission tomography study. J Nucl Cardiol (2007) 0.95
Evaluation of myocardial ischemia using a rest metabolism/stress perfusion protocol with fluorine-18 deoxyglucose/technetium-99m MIBI and dual-isotope simultaneous-acquisition single-photon emission computed tomography. J Am Coll Cardiol (1995) 0.95
Imaging myocardial metabolism and ischemic memory. Nat Clin Pract Cardiovasc Med (2008) 0.94
PET measurements of myocardial glucose metabolism with 1-11C-glucose and kinetic modeling. J Nucl Med (2007) 0.93
Significance of reduced uptake of iodinated fatty acid analogue for the evaluation of patients with acute chest pain. J Am Coll Cardiol (2001) 0.92
Postnatal expression and activity of the mitochondrial 2-oxoglutarate-malate carrier in intact hearts. Am J Physiol Cell Physiol (2000) 0.90
Recruitment of NADH shuttling in pressure-overloaded and hypertrophic rat hearts. Am J Physiol Cell Physiol (2007) 0.89
Direct comparison of fluorine-18-FDG SPECT, fluorine-18-FDG PET and rest thallium-201 SPECT for detection of myocardial viability. J Nucl Med (1995) 0.87
Quantitative assessment of prolonged metabolic abnormalities in reperfused canine myocardium. Circulation (1992) 0.86
Substrate-dependent proton load and recovery of stunned hearts during pyruvate dehydrogenase stimulation. Am J Physiol Heart Circ Physiol (2000) 0.84
L-3-11C-lactate as a PET tracer of myocardial lactate metabolism: a feasibility study. J Nucl Med (2007) 0.84
Mitochondrial preference for short chain fatty acid oxidation during coronary artery constriction. Circulation (2002) 0.84
Fluorine-18-deoxyglucose SPECT and coincidence imaging for myocardial viability: Clinical and technologic issues. J Nucl Cardiol (2001) 0.82
Myocardial scintigraphy using a fatty acid analogue detects coronary artery disease in hemodialysis patients. Kidney Int (2004) 0.81
Myocardial high-energy phosphate metabolism and allograft rejection in patients with heart transplants. Radiology (1991) 0.81
Deleterious effect of altered myocardial fatty acid metabolism in kidney disease. J Am Coll Cardiol (2008) 0.80
In vivo assessment of myocardial glucose uptake by positron emission tomography in adults with the PRKAG2 cardiac syndrome. Circ Cardiovasc Imaging (2009) 0.80
Myocardial contrast echocardiography can be used to assess the microvascular response to vascular endothelial growth factor-121. Circulation (2002) 0.80
Comparison of myocardial uptake of fluorine-18-fluorodeoxyglucose imaged with PET and SPECT in dyssynergic myocardium. J Nucl Med (1996) 0.78
Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Int J Cardiovasc Imaging (2002) 2.95
We are all for elevating VR…. JACC Cardiovasc Imaging (2011) 2.62
Patient management after noninvasive cardiac imaging results from SPARC (Study of myocardial perfusion and coronary anatomy imaging roles in coronary artery disease). J Am Coll Cardiol (2012) 2.60
Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia. J Am Coll Cardiol (2011) 2.51
Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine. Cancer Res (2005) 2.34
Does quantification of myocardial flow reserve using rubidium-82 positron emission tomography facilitate detection of multivessel coronary artery disease? J Nucl Cardiol (2012) 1.90
Quantification of myocardial blood flow with 82Rb dynamic PET imaging. Eur J Nucl Med Mol Imaging (2007) 1.85
Ultrasound imaging of acute cardiac transplant rejection with microbubbles targeted to intercellular adhesion molecule-1. Circulation (2003) 1.83
Effect of cardiac resynchronization on myocardial efficiency and regional oxidative metabolism. Circulation (2003) 1.83
Why all the focus on cardiac imaging? JACC Cardiovasc Imaging (2010) 1.68
Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. J Nucl Cardiol (2002) 1.68
Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial. JACC Cardiovasc Imaging (2009) 1.63
A novel hydrodynamic approach to the treatment of coronary artery disease. Eur Heart J (2006) 1.62
Recruitment of compensatory pathways to sustain oxidative flux with reduced carnitine palmitoyltransferase I activity characterizes inefficiency in energy metabolism in hypertrophied hearts. Circulation (2007) 1.59
Modulating targeted adhesion of an ultrasound contrast agent to dysfunctional endothelium. Ann Biomed Eng (2002) 1.59
18F-FDG PET imaging of myocardial viability in an experienced center with access to 18F-FDG and integration with clinical management teams: the Ottawa-FIVE substudy of the PARR 2 trial. J Nucl Med (2010) 1.56
Targeted ultrasound contrast agents: in vitro assessment of endothelial dysfunction and multi-targeting to ICAM-1 and sialyl Lewisx. Biotechnol Bioeng (2005) 1.53
The effects of continuous positive airway pressure on myocardial energetics in patients with heart failure and obstructive sleep apnea. J Am Coll Cardiol (2007) 1.53
The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience. J Nucl Med (2012) 1.52
What is the prognostic value of myocardial perfusion imaging using rubidium-82 positron emission tomography? J Am Coll Cardiol (2006) 1.52
The transcriptional coactivator PGC-1alpha is essential for maximal and efficient cardiac mitochondrial fatty acid oxidation and lipid homeostasis. Am J Physiol Heart Circ Physiol (2008) 1.51
Second window of preconditioning normalizes palmitate use for oxidation and improves function during low-flow ischaemia. Cardiovasc Res (2011) 1.49
Single low-dose CT scan optimized for rest-stress PET attenuation correction and quantification of coronary artery calcium. J Nucl Cardiol (2014) 1.46
Prognostic significance of impaired chronotropic response to pharmacologic stress Rb-82 PET. J Nucl Cardiol (2014) 1.46
Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making. J Am Coll Cardiol (2013) 1.44
Accuracy of low-dose rubidium-82 myocardial perfusion imaging for detection of coronary artery disease using 3D PET and normal database interpretation. J Nucl Cardiol (2012) 1.44
Pre-clinical myocardial metabolic alterations in chronic kidney disease. Cardiology (2010) 1.43
Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health. JACC Cardiovasc Imaging (2010) 1.39
Detection of elevated right atrial pressure using a simple bedside ultrasound measure. Am Heart J (2010) 1.38
Does FDG PET-assisted management of patients with left ventricular dysfunction improve quality of life? A substudy of the PARR-2 trial. Can J Cardiol (2011) 1.37
Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up. Circulation (2005) 1.32
Preferential oxidation of triacylglyceride-derived fatty acids in heart is augmented by the nuclear receptor PPARalpha. Circ Res (2010) 1.30
The absence of endogenous lipid oxidation in early stage heart failure exposes limits in lipid storage and turnover. J Mol Cell Cardiol (2007) 1.30
Integration of three-dimensional scar maps for ventricular tachycardia ablation with positron emission tomography-computed tomography. JACC Cardiovasc Imaging (2008) 1.29
American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy: Endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr (2011) 1.28
Cardiac sarcoidosis: applications of imaging in diagnosis and directing treatment. Heart (2011) 1.26
Multimodality cardiovascular molecular imaging, part I. Circ Cardiovasc Imaging (2008) 1.25
Report of the National Heart, Lung, and Blood Institute working group on the translation of cardiovascular molecular imaging. Circulation (2011) 1.23
Iodofiltic acid I 123 (BMIPP) fatty acid imaging improves initial diagnosis in emergency department patients with suspected acute coronary syndromes: a multicenter trial. J Am Coll Cardiol (2010) 1.22
Targeted in vivo labeling of receptors for vascular endothelial growth factor: approach to identification of ischemic tissue. Circulation (2003) 1.21
Ultrasound-targeted microbubble destruction to deliver siRNA cancer therapy. Cancer Res (2012) 1.18
Quantitative analysis of coronary endothelial function with generator-produced 82Rb PET: comparison with 15O-labelled water PET. Eur J Nucl Med Mol Imaging (2010) 1.17
Accelerated triacylglycerol turnover kinetics in hearts of diabetic rats include evidence for compartmented lipid storage. Am J Physiol Endocrinol Metab (2005) 1.16
Coupling of mitochondrial fatty acid uptake to oxidative flux in the intact heart. Biophys J (2002) 1.15
Quantification of myocardial blood flow and flow reserve: Technical aspects. J Nucl Cardiol (2010) 1.12
Gene therapy of carcinoma using ultrasound-targeted microbubble destruction. Ultrasound Med Biol (2011) 1.09
Low-level ionizing radiation from noninvasive cardiac imaging: can we extrapolate estimated risks from epidemiologic data to the clinical setting? JACC Cardiovasc Imaging (2010) 1.04
SNMMI/ASNC/SCCT guideline for cardiac SPECT/CT and PET/CT 1.0. J Nucl Med (2013) 1.04
Limited transfer of cytosolic NADH into mitochondria at high cardiac workload. Am J Physiol Heart Circ Physiol (2004) 1.02
Effect of acoustic conditions on microbubble-mediated microvascular sonothrombolysis. Ultrasound Med Biol (2012) 1.01
Targeted PET/CT imaging of vulnerable atherosclerotic plaques: microcalcification with sodium fluoride and inflammation with fluorodeoxyglucose. Curr Cardiol Rep (2013) 0.98
Matrix revisited: mechanisms linking energy substrate metabolism to the function of the heart. Circ Res (2014) 0.98
New insights into mechanisms of sonothrombolysis using ultra-high-speed imaging. Ultrasound Med Biol (2013) 0.98
Molecular imaging of amyloidosis: will the heart be the next target after the brain? Curr Cardiol Rep (2012) 0.97
Variation of heart-to-mediastinal ratio in (123)I-mIBG cardiac sympathetic imaging: its affecting factors and potential corrections. Curr Cardiol Rep (2011) 0.94
Imaging myocardial metabolism and ischemic memory. Nat Clin Pract Cardiovasc Med (2008) 0.94
Assessment of myocardial ischaemia and viability: role of positron emission tomography. Eur Heart J (2010) 0.91
Usefulness of beta-blocker therapy and outcomes in patients with pulmonary arterial hypertension. Am J Cardiol (2012) 0.91
Principal strain changes precede ventricular wall thinning during transition to heart failure in a mouse model of dilated cardiomyopathy. Am J Physiol Heart Circ Physiol (2007) 0.91
Ultra-fast bright field and fluorescence imaging of the dynamics of micrometer-sized objects. Rev Sci Instrum (2013) 0.90
Incremental value of cardiac imaging in patients presenting to the emergency department with chest pain and without ST-segment elevation: a multicenter study. Am Heart J (2004) 0.90
Early imaging in heart failure: exploring novel molecular targets. J Nucl Cardiol (2007) 0.90
18F-FDG PET/CT in a recurrent diffuse malignant peritoneal mesothelioma. Clin Nucl Med (2012) 0.90
Clinical application of PET/CT fusion imaging for three-dimensional myocardial scar and left ventricular anatomy during ventricular tachycardia ablation. J Cardiovasc Electrophysiol (2009) 0.90
Modulation of pre-capillary arteriolar pressure with drag-reducing polymers: a novel method for enhancing microvascular perfusion. Microcirculation (2012) 0.89
Cardiac positron emission tomography: current clinical practice. Cardiol Clin (2009) 0.88
Efficient, cardiac-specific adenoviral gene transfer in rat heart by isolated retrograde perfusion in vivo. Gene Ther (2005) 0.88
Will 3-dimensional PET-CT enable the routine quantification of myocardial blood flow? J Nucl Cardiol (2007) 0.88
Chronic ischemic left ventricular dysfunction: from pathophysiology to imaging and its integration into clinical practice. JACC Cardiovasc Imaging (2008) 0.88
Strategies for defining an optimal risk-benefit ratio for stress myocardial perfusion SPECT. J Nucl Cardiol (2011) 0.88
Multiphasic triacylglycerol dynamics in the intact heart during acute in vivo overexpression of CD36. J Lipid Res (2012) 0.87
Optimization of ultrasound contrast agents with computational models to improve selection of ligands and binding strength. Biotechnol Bioeng (2010) 0.87
Quantification of plaque neovascularization using contrast ultrasound: a histologic validation. Eur Heart J (2010) 0.86
American Society of Echocardiography Cardiovascular Technology and Research Summit: a roadmap for 2020. J Am Soc Echocardiogr (2013) 0.86
The clinical utility of assessing myocardial blood flow using positron emission tomography. J Nucl Cardiol (2010) 0.86
Ultrasound mediated destruction of DNA-loaded microbubbles for enhancement of cell-based therapies: new promise amidst a confluence of uncertainties? JACC Cardiovasc Imaging (2009) 0.86
Early impairment of transmural principal strains in the left ventricular wall after short-term, high-fat feeding of mice predisposed to cardiac steatosis. Circ Cardiovasc Imaging (2010) 0.86
Noninvasive detection of lipids in atherosclerotic plaque using ultrasound thermal strain imaging: in vivo animal study. J Am Coll Cardiol (2013) 0.86
Tracking stem cell therapy in the myocardium: applications of positron emission tomography. Curr Pharm Des (2008) 0.86
SERCA1 expression enhances the metabolic efficiency of improved contractility in post-ischemic heart. J Mol Cell Cardiol (2009) 0.86
Ultrasound detection of myocardial ischemic memory using an E-selectin targeting peptide amenable to human application. Mol Imaging (2014) 0.85
18F-FDG PET/CT in a rare malignant extraskeletal osteosarcoma. Clin Nucl Med (2013) 0.85
New insights into the microvascular mechanisms of drag reducing polymers: effect on the cell-free layer. PLoS One (2013) 0.85
Brief increase in carbohydrate oxidation after reperfusion reverses myocardial stunning in conscious pigs. Circulation (2002) 0.85
The potential of FDG PET/CT for early diagnosis of cardiac device and prosthetic valve infection before morphologic damages ensue. Curr Cardiol Rep (2014) 0.85
Characterizing the normal range of myocardial blood flow with ⁸²rubidium and ¹³N-ammonia PET imaging. J Nucl Cardiol (2013) 0.84
Imaging atherosclerosis with hybrid [18F]fluorodeoxyglucose positron emission tomography/computed tomography imaging: what Leonardo da Vinci could not see. J Nucl Cardiol (2012) 0.84
A novel hydrodynamic method for microvascular flow enhancement. Biorheology (2009) 0.84
Cardiovascular imaging: new directions in an evolving landscape. Can J Cardiol (2013) 0.84
Expression of slow skeletal TnI in adult mouse hearts confers metabolic protection to ischemia. J Mol Cell Cardiol (2011) 0.83
Sexual dimorphism in cardiac triacylglyceride dynamics in mice on long term caloric restriction. J Mol Cell Cardiol (2011) 0.83
Drag reducing polymers improve coronary flow reserve through modulation of capillary resistance. Biorheology (2009) 0.83
Assessment of myocardial viability by radionuclide and echocardiographic techniques: is it simply a sensitivity and specificity issue? Curr Opin Cardiol (2006) 0.83
Effect of coronary stenosis on adjacent bed flow reserve: assessment of microvascular mechanisms using myocardial contrast echocardiography. Circulation (2006) 0.83
Vascular endoluminal delivery of mesenchymal stem cells using acoustic radiation force. Tissue Eng Part A (2011) 0.83
Relation between right ventricular function and increased right ventricular [18F]fluorodeoxyglucose accumulation in patients with heart failure. Circ Cardiovasc Imaging (2010) 0.83
Noninvasive assessment of right ventricular function: will there be resurgence in radionuclide imaging techniques? Curr Cardiol Rep (2010) 0.83
Assessing Cardiac Metabolism: A Scientific Statement From the American Heart Association. Circ Res (2016) 0.82